| 报告期 | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 531,675,455.34 | 696,733,016.41 | 325,191,295.98 | 540,925,061.47 |
| 收到的税费返还 | 7,595.89 | 23,529.42 | 27,141.48 | 940,202.4 |
| 收到其他与经营活动有关的现金 | 11,067,508.74 | 10,319,271.26 | 3,155,321.43 | 104,789,520.94 |
| 经营活动现金流入小计 | 542,750,559.97 | 707,075,817.09 | 328,373,758.89 | 646,654,784.81 |
| 购买商品、接受劳务支付的现金 | 371,333,797 | 449,838,581.34 | 246,790,398.62 | 448,584,486.59 |
| 支付给职工以及为职工支付的现金 | 95,768,542 | 156,111,383.55 | 85,888,305.29 | 163,141,328.68 |
| 支付的各项税费 | 25,360,382.03 | 54,575,828.64 | 18,632,924.09 | 28,877,809.47 |
| 支付其他与经营活动有关的现金 | 34,810,452.63 | 89,507,442.54 | 46,312,969.41 | 103,494,286.43 |
| 经营活动现金流出小计 | 527,273,173.66 | 750,033,236.07 | 397,624,597.41 | 744,097,911.17 |
| 经营活动产生的现金流量净额 | 15,477,386.31 | -42,957,418.98 | -69,250,838.52 | -97,443,126.36 |
| 二、投资活动产生的现金流量: | | | | |
| 收回投资收到的现金 | 93,612,491.67 | 328,312,531.44 | 201,385,887.9 | 91,180,081.22 |
| 取得投资收益收到的现金 | - | 83,836.77 | 3,300 | 4,699.2 |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | 52,675,101 | 121,023,853.77 | 57,974,000 | 401,505,138 |
| 收到的其他与投资活动有关的现金 | - | - | - | 16,392,339.81 |
| 投资活动现金流入小计 | 146,287,592.67 | 449,420,221.98 | 259,363,187.9 | 509,082,258.23 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 27,310,874.78 | 67,248,882.62 | 9,570,981.41 | 157,631,015.06 |
| 投资支付的现金 | 72,608,430.2 | 361,028,027.95 | 194,250,743.95 | 126,530,005.56 |
| 投资活动现金流出小计 | 99,919,304.98 | 428,276,910.57 | 203,821,725.36 | 284,161,020.62 |
| 投资活动产生的现金流量净额 | 46,368,287.69 | 21,143,311.41 | 55,541,462.54 | 224,921,237.61 |
| 三、筹资活动产生的现金流量: | | | | |
| 吸收投资收到的现金 | - | 2,777,600 | 2,777,600 | 29,778,091.76 |
| 其中:子公司吸收少数股东投资收到的现金 | - | 2,777,600 | 2,777,600 | 29,778,091.76 |
| 取得借款收到的现金 | 15,000,000 | 48,000,000 | 25,000,000 | 5,000,000 |
| 收到其他与筹资活动有关的现金 | 60,000,000 | 30,000,000 | - | 119,620,000 |
| 筹资活动现金流入小计 | 75,000,000 | 80,777,600 | 27,777,600 | 154,398,091.76 |
| 偿还债务支付的现金 | 58,500,000 | 13,300,000 | 2,800,000 | 208,944,022.73 |
| 分配股利、利润或偿付利息支付的现金 | 22,354,662.19 | 5,471,146.17 | 2,460,440.31 | 8,645,944.42 |
| 支付其他与筹资活动有关的现金 | 77,100,000 | 18,514,702.29 | - | 89,602,557.16 |
| 筹资活动现金流出小计 | 157,954,662.19 | 37,285,848.46 | 5,260,440.31 | 307,192,524.31 |
| 筹资活动产生的现金流量净额 | -82,954,662.19 | 43,491,751.54 | 22,517,159.69 | -152,794,432.55 |
| 五、现金及现金等价物净增加额 | -21,108,988.19 | 21,677,643.97 | 8,807,783.71 | -25,316,321.3 |
| 加:期初现金及现金等价物余额 | 32,707,075.44 | 11,029,431.47 | 11,848,877.99 | 36,345,752.77 |
| 期末现金及现金等价物余额 | 11,598,087.25 | 32,707,075.44 | 20,656,661.7 | 11,029,431.47 |
| 补充资料: | | | | |
| 净利润 | 4,587,045.33 | -92,909,477.31 | -100,746,327.61 | -320,348,843.89 |
| 资产减值准备 | - | 17,104,215.56 | - | -26,968,403.87 |
| 固定资产和投资性房地产折旧 | 6,092,677.92 | 13,086,813.9 | 6,437,088.47 | 18,832,234.78 |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 6,092,677.92 | 13,086,813.9 | 6,437,088.47 | 18,832,234.78 |
| 无形资产摊销 | 182,995.92 | 490,248.27 | 267,936.7 | 1,765,415.15 |
| 长期待摊费用摊销 | 1,953,582.39 | 2,456,438.68 | 601,610.07 | 3,182,662.46 |
| 处置固定资产、无形资产和其他长期资产的损失 | 298,869.67 | -27,656,755.89 | 2,580,907.78 | 25,245,228.91 |
| 固定资产报废损失 | - | 33,730.12 | - | 117,755.45 |
| 财务费用 | 11,363,974.36 | 15,529,413.11 | 7,952,878.85 | 20,123,621.03 |
| 投资损失 | -298,386.25 | -479,311.19 | -149,002.03 | -294,618.3 |
| 递延所得税 | -2,373,647.94 | -1,712,565.24 | -762,447.95 | -2,800,754.42 |
| 其中:递延所得税资产减少 | -4,394,322.84 | -1,012,228.97 | 379,803.97 | -4,419,907.89 |
| 递延所得税负债增加 | 2,020,674.9 | -700,336.27 | -1,142,251.92 | 1,619,153.47 |
| 存货的减少 | -6,734,864.35 | 144,470,363.19 | -10,806,790.43 | 53,188,425.01 |
| 经营性应收项目的减少 | 55,473,239.83 | -302,728,998.99 | 88,349,711.86 | -207,237,475.46 |
| 经营性应付项目的增加 | 33,882,058.57 | 203,958,178.9 | -79,318,141.75 | 366,554,016.61 |
| 现金的期末余额 | 11,598,087.25 | 32,707,075.44 | 20,656,661.7 | 11,029,431.47 |
| 减:现金的期初余额 | 32,707,075.44 | 11,029,431.47 | 11,848,877.99 | 36,345,752.77 |
| 现金及现金等价物的净增加额 | -21,108,988.19 | 21,677,643.97 | 8,807,783.71 | -25,316,321.3 |
| 公告日期 | 2026-08-28 | 2026-04-28 | 2025-08-18 | 2025-04-30 |
| 审计意见(境内) | | 带强调事项段的无保留意见 | | 带强调事项段的无保留意见 |